Alcanza Clinical Research

According to the CDC, the number of drug overdose deaths has increased by nearly 5 percent from 2018 to 2019 and has quadrupled since it began in 1999.

The CDC is committed to fighting the epidemic, and now, Accel Research Sites is joining that effort in Central Florida. The company is conducting a clinical trial aimed at providing help to opioid users. Dr. James Andersen is the principal investigator on the trial, which will be conducted out of Accel Research Sites’ Lakeland location.

“Opioid users might be stigmatized, but they are often the people we know and love,” Dr. Andersen said. “Clinical trials like these are a way for people who might feel shame or hopelessness to get help themselves and potentially help many other people in the future.”

The trial is seeking opioid users who are not currently being treated as well as those who are receiving treatment but are still using. The goal of the trial is to reduce their opioid use.

Accel Research Sites is hoping to enroll hundreds of patients in the trial. If you or your loved one are eligible to participate, all study-related care will be provided at no cost, no health insurance required. Compensation for time and travel may also be provided.

Those interested in participating should fill out the form by clicking this link.

A representative from Accel will reach out to determine further eligibility.

Accel Research Sites offers a network of clinical research sites in three states. The organization is capable of running a wide variety of clinical trials and aims to further the medical field and advance wellness and healthcare.